ZA200107913B - Modulators of beta-amyloid peptide aggregation comprising D-amino acids. - Google Patents
Modulators of beta-amyloid peptide aggregation comprising D-amino acids.Info
- Publication number
- ZA200107913B ZA200107913B ZA200107913A ZA200107913A ZA200107913B ZA 200107913 B ZA200107913 B ZA 200107913B ZA 200107913 A ZA200107913 A ZA 200107913A ZA 200107913 A ZA200107913 A ZA 200107913A ZA 200107913 B ZA200107913 B ZA 200107913B
- Authority
- ZA
- South Africa
- Prior art keywords
- peptide
- amyloid peptide
- group
- compounds
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12273699P | 1999-03-04 | 1999-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200107913B true ZA200107913B (en) | 2002-11-27 |
Family
ID=22404455
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200107913A ZA200107913B (en) | 1999-03-04 | 2001-09-26 | Modulators of beta-amyloid peptide aggregation comprising D-amino acids. |
Country Status (19)
Country | Link |
---|---|
US (3) | US6610658B1 (da) |
EP (1) | EP1161449B1 (da) |
JP (2) | JP2002543043A (da) |
KR (1) | KR100771712B1 (da) |
CN (1) | CN1279053C (da) |
AT (1) | ATE366259T1 (da) |
AU (1) | AU781292B2 (da) |
BR (1) | BR0008738A (da) |
CA (1) | CA2362834C (da) |
CY (1) | CY1106899T1 (da) |
DE (1) | DE60035412T2 (da) |
DK (1) | DK1161449T3 (da) |
ES (1) | ES2290023T3 (da) |
HK (1) | HK1040722B (da) |
NZ (1) | NZ514414A (da) |
PT (1) | PT1161449E (da) |
RU (1) | RU2260599C2 (da) |
WO (1) | WO2000052048A1 (da) |
ZA (1) | ZA200107913B (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6277826B1 (en) * | 1996-08-27 | 2001-08-21 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
WO1997021728A1 (en) | 1995-12-12 | 1997-06-19 | Karolinska Innovations Ab | PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
US6610658B1 (en) * | 1999-03-04 | 2003-08-26 | Praecis Pharmaceuticals Inc. | Modulators of μ-amyloid peptide aggregation |
US7060670B1 (en) | 1999-05-05 | 2006-06-13 | Neurochem (International) Limited | Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
GB9917725D0 (en) * | 1999-07-28 | 1999-09-29 | Medical Res Council | Peptides |
US20020094335A1 (en) * | 1999-11-29 | 2002-07-18 | Robert Chalifour | Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
US20070135337A2 (en) * | 1999-11-29 | 2007-06-14 | Neurochem (International) Limited | Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases |
WO2001058470A2 (en) * | 2000-02-11 | 2001-08-16 | Praecis Pharmaceuticals Incorporated | Methods for enhancing the bioavailability of a drug |
AUPR215700A0 (en) * | 2000-12-19 | 2001-01-25 | Fujisawa Pharmaceutical Co., Ltd. | Carboxylic acid compound having cyclopropane ring |
DE10117281A1 (de) * | 2001-04-06 | 2002-10-24 | Inst Molekulare Biotechnologie | Peptid zur Diagnose und Therapie der Alzheimer-Demenz |
EP1499729B9 (en) | 2002-04-18 | 2012-03-14 | Yeda Research And Development Co., Ltd. | Derivatives of the nf-kappab inducing enzyme, their preparation and use |
WO2004058239A1 (en) * | 2002-12-24 | 2004-07-15 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
CN100340599C (zh) * | 2003-06-09 | 2007-10-03 | 湖南大学 | 多聚赖氨酸淀粉纳米颗粒与制备方法及作为基因载体的应用 |
GB0503434D0 (en) * | 2005-02-18 | 2005-03-30 | Senexis Ltd | Amyloid-binding peptides, analogues and uses thereof |
JO2824B1 (en) * | 2005-12-12 | 2014-09-15 | اف . هوفمان لاروش ايه جي | Antibody glycosylate in the changing region |
WO2008099210A2 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
DE102008037564A1 (de) * | 2008-11-19 | 2010-05-20 | Forschungszentrum Jülich GmbH | Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden |
BR112012013662B1 (pt) * | 2009-12-07 | 2022-08-02 | Pieris Pharmaceuticals Gmbh | Muteínas de lipocalina associada à gelatinase de neutrófilo humano (lcn2, hngal), seu uso e seus métodos de geração e produção, molécula de ácido nucleico, célula hospedeira, composição farmacêutica e kit de diagnóstico ou analítico |
US10653631B2 (en) | 2011-09-07 | 2020-05-19 | Roland SAUR-BROSCH | Optimal colon targeting technology |
AU2012305915B2 (en) | 2011-09-07 | 2017-09-07 | Roland Saur-Brosch | Formulation for the controlled release of one or several substances in the digestive tract of a mammal |
KR101437354B1 (ko) * | 2012-07-27 | 2014-09-05 | 한국과학기술연구원 | 고수율 및 고순도의 아밀로이드-베타 펩타이드의 제조방법 |
KR20230128606A (ko) * | 2022-02-28 | 2023-09-05 | 경상국립대학교산학협력단 | 티로신을 유효성분으로 함유하는 알츠하이머병의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR82516E (fr) * | 1962-10-11 | 1964-02-28 | Ciba Geigy | Procédé de préparation de dérivés peptidiques, notamment d'hydrazides peptidiques |
US4119493A (en) | 1975-10-23 | 1978-10-10 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
US5284664A (en) | 1988-08-04 | 1994-02-08 | Kremers-Urban Company | Method of treating the symptoms of Alzheimer's disease |
US5652214A (en) | 1989-06-05 | 1997-07-29 | Cephalon, Inc. | Treating disorders by application of insulin-like growth factors and analogs |
US5338663A (en) | 1990-08-24 | 1994-08-16 | President And Fellows Of Harvard College | Method of identifying inhibitors of β-protein esterase activity |
US5434050A (en) | 1991-08-13 | 1995-07-18 | Regents Of The University Of Minnesota | Labelled β-amyloid peptide and methods of screening for Alzheimer's disease |
US5338837A (en) | 1991-12-13 | 1994-08-16 | The Trustees Of Princeton University | Glycosylated steroid derivatives for transport across biological membranes and process for making same |
US5766846A (en) | 1992-07-10 | 1998-06-16 | Athena Neurosciences | Methods of screening for compounds which inhibit soluble β-amyloid peptide production |
US6120768A (en) | 1993-05-17 | 2000-09-19 | Immunomedics, Inc. | Dota-biotin derivatives |
WO1994028412A1 (en) | 1993-05-28 | 1994-12-08 | The Miriam Hospital | Composition and method for in vivo imaging of amyloid deposits |
US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
CA2125467C (en) | 1993-07-06 | 2001-02-06 | Heinz Dobeli | Process for producing hydrophobic polypeptides, proteins or peptides |
AU7556994A (en) | 1993-08-13 | 1995-03-14 | Molecular Geriatrics Corporation | Methods for the diagnosis of alzheimer's disease |
GB9317120D0 (en) | 1993-08-17 | 1993-09-29 | Royal Postgrad Med School | Human serum amyloid p component |
US5652334A (en) | 1993-09-08 | 1997-07-29 | City Of Hope | Method for design of substances that enhance memory and improve the quality of life |
US5470951A (en) | 1993-09-29 | 1995-11-28 | City Of Hope | Peptides for antagonizing the effects of amyloid βprotein |
US5744368A (en) | 1993-11-04 | 1998-04-28 | Research Foundation Of State University Of New York | Methods for the detection of soluble amyloid β-protein (βAP) or soluble transthyretin (TTR) |
JPH07149668A (ja) | 1993-11-30 | 1995-06-13 | Kanegafuchi Chem Ind Co Ltd | アミロイド沈着検出用物質 |
CA2182731A1 (en) | 1994-02-03 | 1995-08-10 | Michael P. Vitek | Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
US6303567B1 (en) * | 1995-03-14 | 2001-10-16 | Praecis Pharmaceuticals, Inc . | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
EP0815134B1 (en) | 1995-03-14 | 2002-06-05 | Praecis Pharmaceuticals Incorporated | Modulators of amyloid aggregation |
US5767233A (en) | 1995-05-12 | 1998-06-16 | Schering Corporation | Soluble cleavable substrates of the hepatitis C virus protease |
US5985242A (en) | 1995-10-27 | 1999-11-16 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
US6277826B1 (en) * | 1996-08-27 | 2001-08-21 | Praecis Pharmaceuticals, Inc. | Modulators of β-amyloid peptide aggregation comprising D-amino acids |
WO1997021728A1 (en) * | 1995-12-12 | 1997-06-19 | Karolinska Innovations Ab | PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b) |
EP1586584A1 (en) * | 1996-08-27 | 2005-10-19 | Praecis Pharmaceuticals Incorporated | Modulators of beta-amyloid peptide aggregation comprising D-amino acids |
US6610658B1 (en) * | 1999-03-04 | 2003-08-26 | Praecis Pharmaceuticals Inc. | Modulators of μ-amyloid peptide aggregation |
-
2000
- 2000-03-03 US US09/519,019 patent/US6610658B1/en not_active Expired - Fee Related
- 2000-03-03 AT AT00916028T patent/ATE366259T1/de not_active IP Right Cessation
- 2000-03-03 EP EP00916028A patent/EP1161449B1/en not_active Expired - Lifetime
- 2000-03-03 WO PCT/US2000/005574 patent/WO2000052048A1/en active IP Right Grant
- 2000-03-03 AU AU37196/00A patent/AU781292B2/en not_active Ceased
- 2000-03-03 PT PT00916028T patent/PT1161449E/pt unknown
- 2000-03-03 CA CA002362834A patent/CA2362834C/en not_active Expired - Fee Related
- 2000-03-03 CN CNB008071926A patent/CN1279053C/zh not_active Expired - Fee Related
- 2000-03-03 BR BR0008738-6A patent/BR0008738A/pt not_active Application Discontinuation
- 2000-03-03 DE DE60035412T patent/DE60035412T2/de not_active Expired - Lifetime
- 2000-03-03 NZ NZ514414A patent/NZ514414A/xx unknown
- 2000-03-03 KR KR1020017011038A patent/KR100771712B1/ko not_active IP Right Cessation
- 2000-03-03 ES ES00916028T patent/ES2290023T3/es not_active Expired - Lifetime
- 2000-03-03 RU RU2001127246/04A patent/RU2260599C2/ru active
- 2000-03-03 JP JP2000602272A patent/JP2002543043A/ja active Pending
- 2000-03-03 DK DK00916028T patent/DK1161449T3/da active
-
2001
- 2001-09-26 ZA ZA200107913A patent/ZA200107913B/xx unknown
-
2002
- 2002-03-25 HK HK02102235.9A patent/HK1040722B/zh not_active IP Right Cessation
-
2003
- 2003-03-24 US US10/395,290 patent/US6831066B2/en not_active Expired - Fee Related
-
2004
- 2004-11-15 US US10/989,763 patent/US7803774B2/en not_active Expired - Fee Related
-
2007
- 2007-10-02 CY CY20071101254T patent/CY1106899T1/el unknown
-
2010
- 2010-12-24 JP JP2010287097A patent/JP2011121952A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1161449B1 (en) | 2007-07-04 |
DK1161449T3 (da) | 2007-11-05 |
RU2260599C2 (ru) | 2005-09-20 |
ATE366259T1 (de) | 2007-07-15 |
EP1161449A1 (en) | 2001-12-12 |
JP2002543043A (ja) | 2002-12-17 |
NZ514414A (en) | 2004-02-27 |
CN1279053C (zh) | 2006-10-11 |
CY1106899T1 (el) | 2012-09-26 |
ES2290023T3 (es) | 2008-02-16 |
AU3719600A (en) | 2000-09-21 |
AU781292B2 (en) | 2005-05-12 |
CA2362834C (en) | 2005-12-06 |
US6610658B1 (en) | 2003-08-26 |
KR100771712B1 (ko) | 2007-10-30 |
CA2362834A1 (en) | 2000-09-08 |
DE60035412T2 (de) | 2008-02-14 |
WO2000052048A1 (en) | 2000-09-08 |
JP2011121952A (ja) | 2011-06-23 |
WO2000052048A9 (en) | 2002-04-11 |
HK1040722B (zh) | 2008-02-22 |
US20050137128A1 (en) | 2005-06-23 |
US20030236197A1 (en) | 2003-12-25 |
HK1040722A1 (en) | 2002-06-21 |
DE60035412D1 (de) | 2007-08-16 |
US6831066B2 (en) | 2004-12-14 |
PT1161449E (pt) | 2007-10-12 |
KR20020007316A (ko) | 2002-01-26 |
CN1362967A (zh) | 2002-08-07 |
BR0008738A (pt) | 2001-12-26 |
US7803774B2 (en) | 2010-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106899T1 (el) | Διαμορφωτες συσσωματωσης βητα-αμυλοειδων πεπτιδιων που περιλαμβανουν d-αμινοξεα | |
HK1021741A1 (en) | Modulators of beta-amyloid peptide aggregation comprising d-amino acids | |
DE69713112D1 (de) | Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin-analogen | |
EP2060585A3 (en) | Gene regulatory peptides | |
DE69635493D1 (de) | Verfahren zur herstellung von l-aminosäuren | |
ATE406383T1 (de) | Verkürzte tau proteine | |
IL125590A0 (en) | Peptide immunogens | |
HK1027748A1 (en) | Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glcia glaucoma | |
ATE384077T1 (de) | Stereoselektive antifibrillogene peptide | |
AU6160201A (en) | Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells | |
AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
WO2005060683A3 (en) | Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders | |
PT896615E (pt) | Peptido proveniente de uma forma soluvel de acetilcolinesterase activo como modulador dos canais de calcio | |
DK1353948T3 (da) | Oplöselige biologiske analoge til bata-amyloidpeptid | |
DE59810043D1 (de) | Verfahren zur Herstellung eines pharmazeutisch aktiven Peptides | |
EP1080724A4 (en) | COMPOSITIONS FOR REDUCING MTP ACTIVITY | |
ATE245433T1 (de) | Verwendung von lipopeptiden oder lipoproteinen zur wundbehandlung | |
DK0946590T3 (da) | Dihydroxypropylcysteinpeptid og middel, der indeholder dette peptid | |
EP1870419A3 (en) | Modulators of beta-amyloid peptide aggregation comprising d-amino acids | |
DE69413637D1 (de) | Verwendung von verzweigtkettigen Aminosäuren zur Herstellung eines Arzneimittels zur Behandlung von tardiver Dyskinesia | |
ATE346091T1 (de) | Neues diagnostisches reagens und kit zur erkennung von rickettsiose | |
WO2005041882A3 (en) | Molecules that selectively home to vasculature of premalignant or malignant lesions of the pancreas and other organs | |
NZ508812A (en) | Peptides for the prevention or treatment of HIV | |
AU8981298A (en) | Liquid for evaporative cooling apparatus | |
DE59915086D1 (de) | Rekombinante l-n-carbamoylase aus arthrobacter aurescens, verfahren zur herstellung von l-aminosäuren mittels dieser |